A recent meta-analysis [11] compiling trials that compared intensive management (using insulin) with standard treatment found a small benefit in the intensive therapy group concerning non-fatal myocardial infarction and microalbuminuria, which was offset by a significant risk of severe hypoglycaemia. This evidence concerns the gene INS and Hypoglycemia.